|
|
|
Volumn 16, Issue 3, 2009, Pages 75-76
|
|
Alemtuzumab.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
CANCER ANTIBODY;
IMMUNOLOGICAL ADJUVANT;
MONOCLONAL ANTIBODY;
DISABILITY;
HUMAN;
MULTIPLE SCLEROSIS;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
ADJUVANTS, IMMUNOLOGIC;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
DISABILITY EVALUATION;
HUMANS;
MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 73349108470
PISSN: 13528963
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
